Leukemia chemotherapy in Shanghai Tongji Hospital, International Department
About the clinic
Leukemia treatment at Shanghai Tongji Hospital in Shanghai, China, focuses on advanced immunotherapy methods. The hospital is a leading center for CAR-T cell therapy, having performed over 1,500 infusions for patients with blood cancers. This high volume of procedures makes the facility a major hub for cellular therapy in the region.
Advanced Immunotherapy for Leukemia
The hospital specializes in CAR-T cell therapy for leukemia, lymphoma, and multiple myeloma. This treatment uses the patient's own immune cells to fight cancer. The medical team has practiced this method since 2014, completing over 1,500 infusions. This level of experience helps the staff manage the specific needs of patients during and after the procedure. The center also researches new CAR-NK therapies to offer more options for difficult cases.
Structured Treatment at Shanghai Tongji
Patients follow a clear, standardized pathway for their care. This process starts with careful patient selection to see if immunotherapy is the right choice. It continues through the infusion stage and includes long-term follow-up care. A multidisciplinary tumor board reviews every case. This group includes experts in hematology and radiology to plan the best approach. They also include psychological support to help patients during the recovery process.
Clinical Excellence and Support
Shanghai Tongji Hospital is a tertiary university hospital. It combines clinical care with active medical research. The facility uses a team-based model where different specialists work together on one plan. This helps address the physical and emotional challenges of leukemia. The team tracks patient progress closely after they leave the hospital to monitor health trends. You can leave a request on Bookimed to learn more about the leukemia treatment programs available at this center.
Highlights
Get a free consultation
Individual treatment program and cost estimate
Average answering time – 5 minutes
Accepted payment methods
View more information
Treatments prices in the clinic
| diagnostics | Price | |
|---|---|---|
| Premium Check up | $850 - $1600 |
Clinic Doctors
How are we doing?
Licences
Shanghai Tongji Hospital, International Department: more details about the clinic
Shanghai Tongji Hospital (Shanghai Tongji Hospital), affiliated with Tongji University, is a major public tertiary hospital in Shanghai and one of China’s leading centers for hematology and blood cancer treatment, including lymphoma, leukemia, and multiple myeloma. The Hematology Department and Blood-Tumor Clinical Research Center specialize in advanced cellular immunotherapy, including CAR-T and CAR-NK therapies.
The hospital established its CAR-T program in 2014 and has since performed more than 1,500 CAR-T cell infusions, making it one of the most experienced centers in this field. Over years of clinical development, the team has built a standardized treatment pathway covering patient selection, cell preparation, bridging therapy, infusion, and long-term follow-up. Reported outcomes include a 3-month complete remission rate of approximately 87.5% in lymphoma patients.
For high-risk and refractory cases, the hospital has developed combination approaches such as CAR-T based therapies integrated with additional treatment strategies, improving long-term remission outcomes in selected patient groups. The center has also contributed to the development of innovative approaches such as epigenetic immunotherapy for patients who have not responded to multiple prior treatments.
In lymphoma care, particularly diffuse large B-cell lymphoma (DLBCL), the hospital reports high clinical effectiveness, including strong remission rates in both newly diagnosed and relapsed or refractory cases, significantly improving outcomes compared to conventional therapies.
The hospital is actively involved in global research and clinical innovation, including publications on next-generation CAR-NK cell therapies in leading scientific journals such as Nature Cancer. Its research focuses on improving accessibility, durability, and safety of cellular immunotherapy.
Patient care is organized through a multidisciplinary tumor board involving hematology, radiology, pathology, imaging, nutrition, and psychological support specialists. Advanced diagnostic tools include immunophenotyping for CAR-T eligibility, biopsy techniques, and imaging-guided assessments to ensure precise treatment planning.
Shanghai Tongji Hospital is recognized for its extensive clinical experience in CAR-T therapy, participation in clinical trials, high remission outcomes in lymphoma treatment, and contribution to international research in cellular immunotherapy.
Additional services
Requirements for admission
Patient reviews
Wanyang Qiao
Chung Wah, John Chau
Maxim Beatty
Jay Chen
200 Renmin Ave, People's Square, Huang Pu Qu, Shang Hai Shi, China, 200003
Get a free consultation
Individual treatment program and cost estimate
Average answering time – 5 minutes
How it works:
- We find a medical coordinator familiar with the matter
- You get a personal offer with a step-by-step guide and the cost estimate
- We arrange your travel including appointment scheduling and flights booking
- You arrive at the hospital, we support you 24/7